Alligator Bioscience presents promising interim Phase I data for its bispecific drug candidate ATOR-1015 at AACR
Lund, Sweden, April 27, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX), announces that the company today presents the status of the o ...